Philippines: DOH Extends Suspension of FDA’s New Fees and Charges Under AO No. 2024-0016
On September 5, 2025, the Department of Health (DOH) issued Department Circular No. 2025-0328, officially extending the temporary suspension of Administrative Order (AO) No. 2024-0016 for an additional sixty (60) working days. AO No. 2024-0016 introduces a new schedule of fees and charges for services provided by the Food and Drug Administration (FDA). This extension […]
Philippines: DOH Extends Suspension of FDA’s New Fees and Charges Under AO No. 2024-0016 Read More »





























